airbufo forspiro 320 micrograme/9 micrograme
aeropharm gmbh - germania - combinatii (budesonidum+formoterolum) - pulb. de inhal. unidoza - 320micrograme/9micrograme - adrenergice inhalante adrenergice si alte med. pt. trat. bolilor obstructive c.r
foster 100/6 micrograme pe doza
chiesi farmaceutici s.p.a. - italia - combinatii (beclometasonum+formoterolum) - sol. de inhalat presurizata - 100/6micrograme pe doza - adrenergice inhalante adrenergice si alte med. pt. trat. bolilor obstructive c.r
flutiform 50 micrograme/5 micrograme
mundipharma dc bv - olanda - combinatii (fluticasonum+formoterolum) - susp. de inhalat presurizata - 50micrograme/5micrograme - adrenergice inhalante adrenergice si alte med. pt. trat. bolilor obstructive c.r
flutiform 125 micrograme/5 micrograme
mundipharma dc bv - olanda - combinatii (fluticasonum+formoterolum) - susp. de inhalat presurizata - 125micrograme/5micrograme - adrenergice inhalante adrenergice si alte med. pt. trat. bolilor obstructive c.r
flutiform 250 micrograme/10 micrograme
mundipharma dc bv - olanda - combinatii (fluticasonum+formoterolum) - susp. de inhalat presurizata - 250micrograme/10micrograme - adrenergice inhalante adrenergice si alte med. pt. trat. bolilor obstructive c.r
symbicort 160 micrograme/4,5 micrograme/inhalatie
astrazeneca dunkerque production (azdp) - franta - combinatii (budesonidum+formoterolum) - susp. de inhalat presurizata - 160micrograme/4,5micrograme - adrenergice inhalante adrenergice si alte med. pt. trat. bolilor obstructive c.r
symbicort turbuhaler 160 micrograme/4,5 micrograme/inhalatie
astrazeneca ab - suedia - combinatii (budesonidum+formoterolum) - pulb. de inhal. - 160micrograme/4,5micrograme/inhalatie - adrenergice inhalante adrenergice si alte med. pt. trat. bolilor obstructive c.r
symbicort 80 micrograme/2,25 micrograme/inhalatie
astrazeneca dunkerque production - franta - combinatii (budesonidum+formoterolum) - susp. de inhalat presurizata - 80micrograme/2,25micrograme - adrenergice inhalante adrenergice si alte med. pt. trat. bolilor obstructive c.r
biresp spiromax
teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - medicamente pentru afecțiuni obstructive ale căilor respiratorii, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).
duoresp spiromax
teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - medicamente pentru afecțiuni obstructive ale căilor respiratorii, - asthma duoresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdduoresp spiromax is indicated in adults, aged 18 years and older for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).